Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Steven A. Lubitz, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Steven Lubitz and Lu-Chen Weng.
Steven Lubitz
Connection Strength
7.014
Lu-Chen Weng
  1. Genetic Determinants of Electrocardiographic P-Wave Duration and Relation to Atrial Fibrillation. Circ Genom Precis Med. 2020 10; 13(5):387-395.
    View in: PubMed
    Score: 0.890
  2. Heritability of Atrial Fibrillation. Circ Cardiovasc Genet. 2017 Dec; 10(6).
    View in: PubMed
    Score: 0.737
  3. Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation. Circulation. 2018 03 06; 137(10):1027-1038.
    View in: PubMed
    Score: 0.735
  4. Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium. Sci Rep. 2017 09 12; 7(1):11303.
    View in: PubMed
    Score: 0.726
  5. Predictive Accuracy of a Clinical and Genetic Risk Model for Atrial Fibrillation. Circ Genom Precis Med. 2021 10; 14(5):e003355.
    View in: PubMed
    Score: 0.239
  6. Accelerometer-derived physical activity and risk of atrial fibrillation. Eur Heart J. 2021 07 01; 42(25):2472-2483.
    View in: PubMed
    Score: 0.236
  7. Associations Between Alcohol Intake and Genetic Predisposition With Atrial Fibrillation Risk in a National Biobank. Circ Genom Precis Med. 2020 12; 13(6):e003111.
    View in: PubMed
    Score: 0.226
  8. Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke. Stroke. 2020 05; 51(5):1396-1403.
    View in: PubMed
    Score: 0.217
  9. Initial Precipitants and Recurrence of Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2020 03; 13(3):e007716.
    View in: PubMed
    Score: 0.215
  10. Development and Validation of a Prediction Model for Atrial Fibrillation Using Electronic Health Records. JACC Clin Electrophysiol. 2019 11; 5(11):1331-1341.
    View in: PubMed
    Score: 0.209
  11. Electronic physician notifications to improve guideline-based anticoagulation in atrial fibrillation: a randomized controlled trial. J Gen Intern Med. 2018 12; 33(12):2070-2077.
    View in: PubMed
    Score: 0.193
  12. Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults. Circ Arrhythm Electrophysiol. 2018 07; 11(7):e006273.
    View in: PubMed
    Score: 0.192
  13. Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk. Am Heart J. 2018 06; 200:24-31.
    View in: PubMed
    Score: 0.188
  14. Factors Associated with Anticoagulation Delay Following New-Onset Atrial Fibrillation. Am J Cardiol. 2017 Oct 15; 120(8):1316-1321.
    View in: PubMed
    Score: 0.180
  15. Atrial Fibrillation Genetic Risk and Ischemic Stroke Mechanisms. Stroke. 2017 06; 48(6):1451-1456.
    View in: PubMed
    Score: 0.177
  16. Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study. Stroke. 2017 02; 48(2):490-492.
    View in: PubMed
    Score: 0.173
  17. Genetic Risk Prediction of Atrial Fibrillation. Circulation. 2017 Apr 04; 135(14):1311-1320.
    View in: PubMed
    Score: 0.171
  18. Whole Exome Sequencing in Atrial Fibrillation. PLoS Genet. 2016 09; 12(9):e1006284.
    View in: PubMed
    Score: 0.169
  19. Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse. Eur Heart J. 2022 Mar 04.
    View in: PubMed
    Score: 0.062
  20. Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank. Nat Genet. 2022 Mar; 54(3):240-250.
    View in: PubMed
    Score: 0.062
  21. Deep learning enables genetic analysis of the human thoracic aorta. Nat Genet. 2022 01; 54(1):40-51.
    View in: PubMed
    Score: 0.061
  22. Rare Coding Variants Associated With Electrocardiographic Intervals Identify Monogenic Arrhythmia Susceptibility Genes: A Multi-Ancestry Analysis. Circ Genom Precis Med. 2021 08; 14(4):e003300.
    View in: PubMed
    Score: 0.059
  23. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature. 2021 02; 590(7845):290-299.
    View in: PubMed
    Score: 0.058
  24. Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease. Circulation. 2021 02 02; 143(5):470-478.
    View in: PubMed
    Score: 0.057
  25. Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease. J Am Coll Cardiol. 2020 06 09; 75(22):2769-2780.
    View in: PubMed
    Score: 0.055
  26. Multi-ancestry GWAS of the electrocardiographic PR interval identifies 202 loci underlying cardiac conduction. Nat Commun. 2020 05 21; 11(1):2542.
    View in: PubMed
    Score: 0.055
  27. Novel Risk Modeling Approach of Atrial Fibrillation With Restricted Mean Survival Times: Application in the Framingham Heart Study Community-Based Cohort. Circ Cardiovasc Qual Outcomes. 2020 04; 13(4):e005918.
    View in: PubMed
    Score: 0.054
  28. Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium whole genome sequences improves imputation quality and detection of rare variant associations in admixed African and Hispanic/Latino populations. PLoS Genet. 2019 12; 15(12):e1008500.
    View in: PubMed
    Score: 0.053
  29. Monogenic and Polygenic Contributions to Atrial Fibrillation Risk: Results From a National Biobank. Circ Res. 2020 01 17; 126(2):200-209.
    View in: PubMed
    Score: 0.053
  30. Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation. JAMA. 2018 12 11; 320(22):2354-2364.
    View in: PubMed
    Score: 0.049
  31. Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes. Neurol Genet. 2018 Dec; 4(6):e293.
    View in: PubMed
    Score: 0.049
  32. Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery. Circulation. 2018 Nov 11.
    View in: PubMed
    Score: 0.049
  33. Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet. 2018 06 11; 50(9):1225-1233.
    View in: PubMed
    Score: 0.048
  34. Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval. Circ Genom Precis Med. 2018 05; 11(5):e002037.
    View in: PubMed
    Score: 0.047
  35. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ. 2018 04 26; 361:k1453.
    View in: PubMed
    Score: 0.047
  36. Diminished PRRX1 Expression Is Associated With Increased Risk of Atrial Fibrillation and Shortening of the Cardiac Action Potential. Circ Cardiovasc Genet. 2017 Oct; 10(5).
    View in: PubMed
    Score: 0.046
  37. Fifteen Genetic Loci Associated With the Electrocardiographic P Wave. Circ Cardiovasc Genet. 2017 Aug; 10(4).
    View in: PubMed
    Score: 0.045
  38. Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet. 2017 07 27; 49(8):1286.
    View in: PubMed
    Score: 0.045
  39. Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet. 2017 Jun; 49(6):946-952.
    View in: PubMed
    Score: 0.044
  40. A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2a. Am J Hum Genet. 2016 Dec 01; 99(6):1281-1291.
    View in: PubMed
    Score: 0.043
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.